M.D. Anderson Cancer Center Archives - PeptideBlog

M.D. Anderson Cancer Center

M.D. Anderson Cancer Center

2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

Registered trials

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Intratumoral Injections of LL37 for Melanoma
NCT02225366
LL-37Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center4Nov 24, 2020Dec 9, 2021
A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity
NCT01262664
AdipotidePhase 1TerminatedM.D. Anderson Cancer Center4Jan 2, 2019Jan 4, 2019

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.